跳至主要内容
临床试验/ACTRN12606000525583
ACTRN12606000525583已完成不适用

A randomised controlled trial on the effects of increasing the protein content of Human Milk Fortifier on growth in preterm infants <31 weeks.

Associate Professor Maria Makrides, Child Nutrition Research Centre0 个研究点目标入组 90 人开始时间: 2006年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
Years 至 3 Years(—)
性别
All

入选标准

  • Infants born <31 weeks gestation at Women's & Children's Hospital Adelaide who are receiving breast milk.

排除标准

  • Infants with major congenital or chromosomal abnormalities which are known to affect growth such as major heart defects, cystic fibrosis.Infants where a high protein intake is contraindicated such as Phenylketonuria, disorders of the urea cycle.

研究者

发起方
Associate Professor Maria Makrides, Child Nutrition Research Centre

相似试验

Protein in Preterm Infant Nutrition (PiPIN) | 临床试验